Skip to content
Screener

Bio-Techne TECH Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Danaher logo
DanaherDHR
$1.2B+9.1%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
5.9%0.0pp
Revvity logo
RevvityRVTY
$163.25M-6.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
4.8%+0.7pp
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$347.66M-7.5%
Agilent Technologies logo
Agilent TechnologiesA
——

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.2B+43.3%
Enterprise value$11.28B+39.3%
P/E74.8×+16.8×
P/S9.3×+2.8×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemMarch 31, 2026 / (unaudited)June 30, 2025
Other current assets62,49437,460
Total current assets688,050608,300
Property and equipment, net232,990245,719
Right-of-use assets68,31673,399
Goodwill977,800980,935
Intangible assets, net319,074365,599
Other assets264,371283,916
Total assets$2,550,601$2,557,868

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's operating lease ROU assets?
Bio-Techne (TECH) reported operating lease ROU assets of $68.32M in Q1 2026.
How has Bio-Techne's operating lease ROU assets changed year-over-year?
Bio-Techne's operating lease ROU assets decreased by 18.4% year-over-year, from $83.74M to $68.32M.
What is the long-term trend for Bio-Techne's operating lease ROU assets?
Over 4 years (2021 to 2025), Bio-Techne's operating lease ROU assets has grown at a -0.1% compound annual growth rate (CAGR), from $73.83M to $73.4M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Bio-Techne's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude